Medtronic Starts New U.S. Study of Endurant AAA Stent Graft

Leading the development of endovascular aortic repair, Medtronic, Inc. MDT today announced the start of its U.S. post-approval study of the Endurant AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!